Navigation Links
Study calls for increased research in flu transmission to prepare for pandemic flu outbreak
Date:2/18/2009

PROVIDENCE, RI Researchers at Rhode Island Hospital have completed a study to better understand the impact of infection control measures during a possible flu pandemic. Their study focused on the likelihood of the transmission of flu from individuals showing no symptoms (asymptomatic) or from individuals who are infected but have not yet exhibited symptoms. The researchers call on the scientific community to better understand the transmission of influenza in order to provide guidelines for effective pandemic flu planning. Their findings are published in the March-April 2009 edition of Public Health Reports.

The study, from Rhode Island Hospital's department of epidemiology and infection control and the division of infectious diseases, notes that public health measures for controlling outbreaks involve isolation of symptomatic individuals and the quarantine of individuals with whom they have had contact. This intervention is dependent upon early identification of symptoms, and the success of the intervention can be limited by transmission that occurs prior to symptom onset and transmission from asymptomatic infection.

Senior author Leonard Mermel, DO, ScM, medical director of the department of epidemiology and infection control at Rhode Island Hospital, along with Eleni Patrozou, MD, performed a systematic review of literature on viral shedding and disease transmission. The review included animal studies, human studies, inoculation experiments, vaccine and antiviral drug efficacy studies, and observations during outbreaks.

Mermel says, "Our findings indicate that pre-symptomatic transmission of influenza has been inferred based on the presence of the virus in the upper respiratory tract rather than from the appropriate transmission experiments. This is troubling because our review of the literature does not support significant influenza transmission based on positive nasopharyngeal cultures in the absence of symptoms."

Their findings also indicate that small-particle aerosols expelled from infected individuals may play a greater role in influenza transmission than previously recognized. The problem, however, is that it remains unclear as to how many of these droplets are generated by asymptomatic or pre-symptomatic individuals.

Mermel adds, "Asymptomatic individuals may shed influenza virus, but studies have not conclusively determined if these individuals effectively transmit influenza to others. Our review of the literature suggests that the role of asymptomatic or pre-symptomatic influenza-infected individuals in disease transmission may have been overestimated in recent articles that have served as the basis for national and international pandemic planning."

He concludes, "Based on the historical record over the last century, we must be prepared for another pandemic. Our research tells us that a better understanding of transmission dynamics is essential if we are to develop effective influenza pandemic plans."


'/>"/>

Contact: Nancy Cawley
ncawley@lifespan.org
Lifespan
Source:Eurekalert

Related medicine news :

1. Statins Pay Off on a Health-Policy Level, UCSF Study Finds
2. Major study on DiagnoCures GCC biomarker published in Jama
3. Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors
4. Newly Published Menopause Study: Bioidentical and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
5. New Study Shares Benchmarks for Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders
6. Study finds that using wakefulness tests to detect daytime sleepiness in drivers may be unreliable
7. Study finds behavioral link between insomnia and tension-type headaches
8. IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
9. Sponsor Dollars Key to Flu Vaccine Study Publication
10. Tobacco Companies Targeting Teens, Study Says
11. New CDC Study Shows Tobacco Marketing Influences Kids to Smoke, Underscores Need for FDA Regulation of Tobacco Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... ... , ... David B. Sosin, a founding partner at the law firm Sosin, ... Vice President for the Illinois State Bar Association , in accordance with the organization’s ... in 2016 following a state-wide election and served in that capacity for the past year ...
(Date:6/28/2017)... Columbia (PRWEB) , ... June 28, 2017 , ... ... (FSE: ZEON) is pleased to announce that a two year study conducted by ... Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As a ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... (PRWEB) , ... June 27, 2017 , ... Harbour ... manage token assets on the Ethereum blockchain, has released their technical specifications . ... now, there has been little systematic approach for determining which offerings will garner the ...
(Date:6/27/2017)... , ... June 27, 2017 , ... From June 20-22, ... three-day event was held in Syracuse, New York, where EarQ is headquartered. , ... how to connect with today’s savvy consumer, and the latest in hearing technology. ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: